Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 23;15(2):162.
doi: 10.3390/life15020162.

Bioinformatic Selection of Mannose-Specific Lectins from Allium genus as SARS-CoV-2 Inhibitors Analysing Protein-Protein Interaction

Stefan Isaković  1 , Milan Senćanski  2 , Vladimir Perović  2 , Kristina Stevanović  2   3 , Ivana Prodić  4
Affiliations

Bioinformatic Selection of Mannose-Specific Lectins from Allium genus as SARS-CoV-2 Inhibitors Analysing Protein-Protein Interaction

Stefan Isaković et al. Life (Basel). .

Abstract

Mannose-specific lectins are carbohydrate-binding proteins known for their antiviral potential. This study uses a bioinformatic approach to investigate the possibility of lectins from Allium sativum (garlic) and Allium ursinum (wild garlic) as inhibitors of SARS-CoV-2 entry. The information spectrum method (ISM) identified key interaction frequencies between the SARS-CoV-2 spike protein and these lectins, explicitly targeting the receptor-binding domain (RBD) and glycosylated asparagine residues, including N234. Lectins from Allium species showed a high affinity for oligomannose-type glycans on the spike protein, potentially blocking virus entry by preventing the spike-ACE2 receptor interaction. We propose that Allium lectins are promising candidates for further experimental validation as SARS-CoV-2 inhibitors, offering potential therapeutic applications in managing viral infections.

Keywords: SARS-CoV-2; bioinformatics; informational spectrum method; lectins; spike protein.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
CS of SARS-CoV-2 S1 protein wild type and human ACE2 receptor.
Figure 2
Figure 2
Corresponding interacting domains in SARS-CoV-2 S1 WT at F(0.323).
Figure 3
Figure 3
(a) Top and (b) side view of SARS-CoV-2 S1 (blue line ribbon) protein trimer with marked interaction domains determined using ISM (yellow line ribbon), N234 residues (red CPK), and glycans (green lines—all, CPK—bound to N234).
Figure 4
Figure 4
CS of SARS-CoV-2 S1 protein wild type and mannose-specific lectin from Allium ursinum.
Figure 5
Figure 5
CS of SARS-CoV-2 S1 protein wild type and mannose-specific lectin from Allium sativum.
Figure 6
Figure 6
CWT plot of SARS-CoV-2 S1 protein wild type at all ISM frequencies.
Figure 7
Figure 7
CWT spectrum of SARS-CoV-2 S1 protein wild type at ISM frequency F(0.323). Grey: wavelet coefficients ≤ cutoff 0.5975; white: wavelet coefficients > cutoff 0.5975.
Figure 8
Figure 8
CS of SARS-CoV-2 wild type S1 protein and lectin Concanavalin A P81461.
Figure 9
Figure 9
(a) CS of HIV-1 gp120 envelope protein and lectin GRFT. (b) CS of H1N1 Hemagglutinin and GNL.
Figure 10
Figure 10
(a) Corresponding interacting domains in HIV-1 gp120 at F(0.334). (b) Corresponding interacting domain in Hemagglutinin H1N1 at F(0.127).
See this image and copyright information in PMC

References

    1. Nabi-Afjadi M., Heydari M., Zalpoor H., Arman I., Sadoughi A., Sahami P., Aghazadeh S. Lectins and lectibodies: Potential promising antiviral agents. Cell. Mol. Biol. Lett. 2022;27:37. doi: 10.1186/s11658-022-00338-4. - DOI - PMC - PubMed
    1. Lagarda-Diaz I., Guzman-Partida A.M., Vazquez-Moreno L. Legume Lectins: Proteins with Diverse Applications. Int. J. Mol. Sci. 2017;18:1242. doi: 10.3390/ijms18061242. - DOI - PMC - PubMed
    1. Van Damme E.J.M., Rougé P. Editorial: Lectins from plants, algae, fungi, bacteria and animal therapeutic tools for SARS-CoV-2 and other pathogenic enveloped viruses, in a “one-health” perspective. Front. Cell Infect. Microbiol. 2023;13:1139691. doi: 10.3389/fcimb.2023.1139691. - DOI - PMC - PubMed
    1. Mitchell C.A., Ramessar K., O’Keefe B.R. Antiviral lectins: Selective inhibitors of viral entry. Antivir. Res. 2017;142:37–54. doi: 10.1016/j.antiviral.2017.03.007. - DOI - PMC - PubMed
    1. Ahmed M.N., Jahan R., Nissapatorn V., Wilairatana P., Rahmatullah M. Plant lectins as prospective antiviral biomolecules in the search for COVID-19 eradication strategies. Biomed. Pharmacother. 2022;146:112507. doi: 10.1016/j.biopha.2021.112507. - DOI - PMC - PubMed

LinkOut - more resources